Indivior Shares Slip After Announcement of $400 Million Convertible Note Offering
Indivior Pharmaceuticals said it will seek to sell $400 million in convertible senior notes due March 15, 2031, in a private placement to qualified institutional buyers. The announcement prompted an approximately 8% decline in the company's stock. The notes will be senior unsecured obligations with semi-annual interest and conversion rights; procee…